Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

BACKGROUND: Graft-versus-host disease (GVHD) remains a major contributor to mortality and morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated recommendations suggest that rabbit antithymocyte globulin or anti-T-lymphocyte globulin (ATG) should be used for GVHD prophylaxis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brissot, Eolia, Labopin, Myriam, Moiseev, Ian, Cornelissen, J. J., Meijer, Ellen, Van Gorkom, Gwendolyn, Rovira, Montserrat, Ciceri, Fabio, Griskevicius, Laimonas, Blaise, Didier, Forcade, Edouard, Mistrik, Martin, Mielke, Stephan, Bulabois, Claude Eric, Niittyvuopio, Riitta, Deconinck, Eric, Ruggeri, Annalisa, Sanz, Jaime, Spyridonidis, Alexandros, Savani, Bipin, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333262/
https://www.ncbi.nlm.nih.gov/pubmed/32620146
http://dx.doi.org/10.1186/s13045-020-00923-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333262/
https://www.ncbi.nlm.nih.gov/pubmed/32620146
http://dx.doi.org/10.1186/s13045-020-00923-0

Ejemplares similares